Neuropharmacological treatments for alcoholism: Scientific basis and clinical findings

Psychopharmacology

Volumn 149, Issue 4, 2000, Pages 327-344

  Johnson, Bankole ^a   Ait Daoud, Nassima ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acamprosate; Alcohol; Fluoxetine; Medications; Nalmefene; Naltrexone; Ondansetron; Ri tanserin; SSRI; Treatment

Indexed keywords

ACAMPROSATE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; MU OPIATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALMEFENE; NALTREXONE; ONDANSETRON; PUERARIN; RITANSERIN; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; DRUG EFFICACY; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0034071789     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000371     Document Type: Review

References (220)

1. al Qatari M, Bouchenafa O, Littleton J (1998) Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 22: 810-814
2. Altshuler HL, Phillips PE, Feinhandler DA (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688
3. Anton RF, Moak DH, Waid R, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo controlled trial. Am J Psychiatry 156:1758-1764
4. Awouters F, Niemegeers CJ, Megens AA, Meert TF, Janssen PA (1988) The pharmacological profile of ritanserin, a very specific central serotonin-S2 antagonist. Drug Dev Res 5:61-73
5. Ballenger J, Goodwin F, Major L, Brown G (1979) Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224-227
6. Barnes N, Sharp S (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
7. 3 antagonists fail to affect ethanol self-administration of rats. Alcohol 11:389-395
8. Benjamin D, Grant ER, Pohorecky LA (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-40
9. Berman RF, Lee JA, Olson KL, Goldman MS (1984) Effects of naloxone on ethanol dependence in rats. Drug Alcohol Depend 13:245-254
10. Biggs T, Myers R (1998) Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats. Pharmacol Biochem Behav 60:407-413
11. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480
12. 3 receptor in CNS disorders. Neurochem 23:653-659
13. Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537-1551
14. Blundell JE, Latham CJ (1982) Behavioural pharmacology of feeding. In: Silverstone T (ed) Drugs and appetite. Academic Press, London
15. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P, Durlach J (1984) A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav 21:787-789
16. Bolo N, Nedelec JF, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP (1998) Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res 82:115-127
17. Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA (1998) Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res 22:359-366
18. Bradbury AJ, Costall B, Domeney AM, Naylor RJ (1985) Laterality of dopamine function and neuroleptic action in the amygdalia in the rat. Neuropharmacology 24:1163-1170
19. Bruno F (1989) Buspirone in the treatment of alcohol patients. Psychopathology 22:49-59
20. Buydens-Branchey L, Noumair D, Branchey MH (1989) Age of alcoholism onset, I. Relationship to psychopathology. Arch Gen Psychiatry 46:225-230
21. Chaillou E, Perre P (1983) The weaning of alcoholic patients in a general medicine hospital department. The value of tiapride. Sem Hop 59:1677-1678
22. Cohen C, Perrault G, Sanger DJ (1997) Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice. Neuropharmacology 36:1099-1108
23. Collins D, Myers R (1987) Buspirone attenuates volitional alcohol intake in chronically drinking monkey. Alcohol 4:49-56
24. Colombo G, Agabio R, Lobina C, Reali R, Melis F, Fadda F, Gessa GL (1995) Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. Alcohol Alcohol 30:125-131
25. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A (1997) Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:700-705
26. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92:881-894
27. Dahchour A, De Witte P, Bolo N, Nedelec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82:107-114
28. 3H) serotonin uptake: role in the voluntary intake of ethanol by rats. Pharmacol Biochem Behav 22:205-208
29. Daoust M, Legrand E, Gewiss M, Heidbreder C, DeWitte P, Tran G, Durbin P (1992) Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacol Biochem Behav 41:669-674
30. Davidson D, Swift R, Fitz E (1996) Naltrexone increases the latency to drink in social drinkers. Alcohol Clin Exp Res 20: 732-739
31. De Beun R, Lohmann A, De Vry J (1996) Conditioned taste aversion and place preference induced by the calcium channel antagonist nimodipine in rats. Pharmacol Biochem Behav 54: 657-663
32. de Figueiredo R (1983) Effect of tiapride in acute manifestations of alcohol withdrawal. Sem Hop 59:2551-2554
33. Delmeire F (1980) Tiapridal. Acta Psychiatr Belg 80:191-201
34. deWit H, Svenson J, York A (1999) Non-specific effects of naltrexone on ethanol consumption in social drinkers. Psychopharmacology 146:33-41
35. DeWitte P (1984) Naloxone reduces alcohol intake in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances. Neuropsychobiology 12: 73-77
36. Di Chiara G, Imperato A (1988) Drug abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
37. Dongier M, Vachon L, Schwartz G (1991) Bromocriptine in the treatment of alcohol dependence. Alcohol Clin Exp Res 15: 970-977
38. Doty P, de Wit H (1995) Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers. Behav Pharmacol 6:386-394
39. Doty P, Zacny J, deWit H (1994) The effects of ondansetron pretreatment on acute responses to ethanol in social drinkers. Behav Pharmacol 5:461-469
40. Dyr W, Kostowski W (1995) Evidence that the amygdala is involved in the inhibitory effects of 5-HT sub3 receptor antagonists on alcohol drinking in rats. Alcohol 12:387-391
41. Dyr W, Krzascik P, Kostowski W (1993) Comparative study of nifedipine and isradipine in animal models of ethanol dependence. Pol J Pharmacol 45:369-79
42. Ehlers CL, Li TK, Lumeng L, Hwang BH, Somes C, Jimenez P, Mathe AA (1998a) Neuropeptide Y levels in ethanol-naive alcohol-preferring and non preferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res 22:1778-82
43. Ehlers CL, Somes C, Cloutier D (1998b) Are some of the effects of ethanol mediated through NPY? Psychopharmacology 139: 136-144
44. Eison AS, Iversen SD, Sandberg BE, Watson SP, Hanley MR, Iversen LL (1982) Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions. Science 215:188-190
45. Evens M (1980) Tiapridal and alcoholic detoxication (author's transl). Acta Psychiatr Belg 80:149-155
46. 3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 26:107-110
47. Fadda F, Garau B, Colombo G, Gessa GL (1992) Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats. Alcohol Clin Exp Res 16:449-452
48. Fantino M (1984) Role of sensory input in the control of food intake. J Auton Nerv Syst 10:347-358
49. Fils-Aime M-L, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M (1996) Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 53:211-216
50. Froehlich JC, Harts J, Lumeng L, Li TK (1987) Naloxone attenuation of voluntary alcohol consumption. Alcohol Alcohol Suppl:333-337
51. Froehlich JC, Harts J, Lumeng L, Li TK (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385-390
52. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK (1991) Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103:467-72
53. Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LD (1997) Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcohol Clin Exp Res 21:1435-1439
54. Geerlings PJ, Ansoms C, van den brink W (1997) Acamprosate and prevention of relapse in alcoholics. Eur Addict Res 3:129-137
55. Geller I (1973) Effects of para-chlorophenylalanine and 5-hydroxytrptophan on alcohol intake in the rat. Pharmacol Biochem Behav 1:362-365
56. George D, Rawlings R, Eckardt M, Phillips M, Shoaf S, Linnoila M (1999) Buspirone treatment of alcoholism: age of onset and cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid concentrations but not medication treatment predict return to drinking. Alcohol Clin Exp Res 23:272-277
57. Gerstin EH Jr, McMahon T, Dadgar J, Messing RO (1998) Protein kinase C delta mediates ethanol-induced up-regulation of L-type calcium channels. J Biol Chem 273:16409-16414
58. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 26:129-137
59. Gianoulakis C (1996) Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcohol Suppl 1:33-42
60. Gianoulakis C (1998) Alcohol-seeking behavior. The roles of the hypothalalmic-pituitary-adrenal axis and the endogenous opioid system. Alcohol Health Res World 22:202-210
61. Gianoulakis C, de Waele JP, Thavundayil J (1996) Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol 13:19-23
62. Gill K, Amit Z (1989) Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Rec Dev Alcohol 7:225-248
63. Gill K, Amit Z, Koe BK (1988a) Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats. Alcohol 5:349-354
64. Gill K, Filion Y, Amit Z (1988b) A further examination of the effects of sertraline on voluntary ethanol consumption. Alcohol 5:355-358
65. Gongwer MA, Murphy JM, McBride WJ, Lumeng L, Li TK (1989) Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high-and low-alcohol drinking lines of rats. Alcohol 6:317-320
66. Gorelick DA, Paredes A (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16: 261-265
67. Gottfies CG (1981) Influence of depression and anti-depressants on weight. Acta Psychiatr Scand Suppl 290:353-356
68. Grahame NJ, Low MJ, Cunningham CL (1998) Intravenous self-administration of ethanol in beta-endorphin-deficient mice. Alcohol Clin Exp Res 22:1093-1098
69. Grisel JE, Grahame NJ, Mogil JS, Belknap JK, Low MJ (1995) Ethanol consumption in transgenic mice lacking β-endorphin. Soc Neurosci Abstr 21:1699
70. Grisel JE, Mogil JS, Grahame NJ, Rubinstein M, Belknap JK, Crabbe JC, Low ML (1999) EtOH oral self-administration is increased in mutant mice with decreased β-endorphin expression. Brain Res (in press)
71. Gysling K, Wang RY (1983) Morphine induced activation of A10 dopamine neurons in the rat. Brain Res 415:257-269
72. 3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br J Pharmacol 99:227-232
73. Haraguchi M, Samson HH, Tolliver GA (1990) Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine. Pharmacol Biochem Behav 35:259-262
74. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
75. Heils A, Mossner R, Lesch KP (1997) The human serotonin transporter gene polymorphism - basic research and clinical implications. J Neural Transm (Budapest) 104:1005-1014
76. Heinz A, Jones D, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger D (1999) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (in press)
77. Hemby SE, Co C, Koves TR, Smith JE, Dworkin SI (1997a) Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 133:7-16
78. Hemby SE, Johnson BA, Dworkin SI (1997b) Neurobiological basis of drug reinforcement. In: Johnson B, Roache J (eds) Drug addiction and its treatment: nexus of neuroscience and behavior. Lippincott-Raven, Philadelphia
79. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99-111
80. 3 antagonist ICS 205-930. Alcohol 10:191-196
81. Ishiguro T, Saito S, Akazawa H, Mitushio H, Tada K, Enomoto H, Mifune M, Toru M, Shibuya H, Arinami T (1999) Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population. 23:1281-1284
82. Jaffe AJ, Rounsaville B, Chang G, Schottenfeld RS, Meyer RE, O'Malley SS (1996) Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol 64:1044-1053
83. 3 receptor interactions in animals and humans. Drug Dev Res 30:153-169
84. Johnson BA, Roache JD (1997) Drug addiction and its treatment: nexus of neuroscience and behavior. Lippincott Raven, Philadelphia, p 448
85. 3 receptor blockade: a preliminary study in healthy male volunteers. Psychopharmacology 112:142-144
86. Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C (1996) Ritanserin in the treatment of alcohol dependence - a multi-center clinical trial. Ritanserin Study Group. Psychopharmacology 128:206-215
87. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda T, Bordnick PS, Ait-Daoud N (1999) Ondansetron and alcohol consumption: preliminary analysis of double-blind trial. In: American Society of Addiction Medicine. The National Institute on Alcohol Abuse and Alcoholism Symposium: Medications Development for Alcoholism, New York
88. Johnson BA, Ait-Davud N, Prihoda T (2000) Combinining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Alcohol Clin Exp Res (in press)
89. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488
90. Kabel DI, Petty F (1996) A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment. Alcohol Clin Exp Res 20:780-784
91. 3 receptors in rat brain using radioligand binding. Nature 330:746-748
92. 4 receptors in terminal regions of the mesolimbic system. Behav Brain Res 73:11-13
93. King AC, Volpicelli JR, Frazer A, O'Brien CP (1997) Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 129:15-22
94. Kirkham TC, Blundell JE (1986) Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharmacol Biochem Behav 25:123-128
95. Koob GF (1992) Neural mechanisms of drug reinforcement. Ann NY Acad Sci 654:171-191
96. Korpi ER, Paivarinta P, Abi-Dargham A, Honkanen A, Laruelle M, Tuominen K, Hilakivi LA (1992) Binding of serotonergic ligands to brain membranes of alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol 9:369-374
97. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N (1995a) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397
98. Kranzler HR, Burleson JA, Korner P, Del Boca FK et al. (1995b) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397
99. Kranzler HR, Burleson J, Brown J, Babor T (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 209:1534-1541
100. Kranzler HR, Modesto-Lowe V, Nuwayser ES (1998) Sustained-release naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 22:1074-1079
101. Kranzler HR, Modesto-Lowe V, Van Kirk JD (2000) Naltrexone versus nefazaolone for treatment of alcohol dependence. A placebo controlled trial. Neuropsychopharmacology 22:493-503
102. Kril JJ, Gundlach AL, Dodd PR, Johnston GA, Harper CG (1989) Cortical dihydropyridine binding sites are unaltered in human alcoholic brain. Ann Neurol 26:395-397
103. Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK, Froehlich JC (1995a) The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology 120:177-185
104. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC (1995b) The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159
105. Lankford M, Bjork A, Myers R (1996) Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats. Alcohol 13:399-404
106. 3 receptor antagonists in the regulation of alcohol intake. Alcohol Alcohol Suppl 2:545-549
107. Le AD, Poulos CX, Quan B, Chou S (1993) The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57B1/6 mice in a restricted access paradigm. Brain Res 630:330-332
108. Le AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21:435-444
109. Le Magnen J, Tran G, Durlach J (1987) Lack of effects of Caacetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Alcohol 4:103-108
110. Leander JD (1987) Fluoxetine suppresses palatability-induced ingestion. Psychopharmacology 91:285-287
111. LeMarquand D, Pihl RO, Benkelfat C (1994a) Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 36:326-337
112. LeMarquand D, Pihl RO, Benkelfat C (1994b) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36:395-421
113. Lesch KP, Meyer J, Glatz K, Flugge G, Hinney A, Hebebrand J, Klauck SM, Poustka A, Poustka F, Bengel D, Mossner R, Riederer P, Heils A (1997) The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Budapest) 104:1259-66
114. Lhuintre JP, Daoust M, Moore N, Chretien P, Saligaut C, Tran G, Boismare F, Hillemand B (1985) Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1:1014-1016
115. Lhuintre JP, Moore N, Tran G, Steru L, Langrenon S, Daoust M, Parot P, Ladure P, Libert C, Boismare F et al. (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25:613-622
116. Li ET, Anderson GH (1983) 5-Hydroxytryptamine control of meal to meal composition chosen by rats. Fed Proc 42:542-548
117. Lin RC, Li TK (1998) Effects of isoflavones on alcohol pharmacokinetics and alcohol-drinking behavior in rats. Am J Clin Nutr 68:1512S-1515S
118. Lin RC, Guthrie S, Xie CY, Mai K, Lee DY, Lumeng L, Li TK (1996) Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 20:659-663
119. Linnoila M, Virkkunen M (1992) Biologic correlates of suicidal risk and aggressive behavioral traits. J Clin Psychopharmacol 12:19S-20S
120. Linnoila M, De Jong J, Virkkunen M (1989) Family history of alcoholism in violent offenders and impulsive fire setters. Arch Gen Psychiatry 46:613-616
121. Litten RZ, Allen J (1998) Advances in the development of medications for alcoholism. Psychopharmacology 139:20-33
122. Litten RZ, Allen J, Fertig J (1996) Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991 [see comments]. Alcohol Clin Exp Res 20:859-876
123. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213
124. Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179-1188
125. 3 receptors and the neural actions of alcohols: an increasingly exciting topic. Neurochem Int 35:125-130
126. 3 receptors on neuroblastoma cells and isolated neurons. Alcohol Alcohol Suppl 1:181-185
127. 3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells. J Neurophysiol 66:1329-1337
128. Lovinger DM, White G (1991) Ethanol potentiation of 5-hydroxy-tryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol Pharmacol 40:263-270
129. 3RA receptors expressed in a mammalian cell line. Neuropharmacology 33:1567-72
130. 3 ligand-gated ion channel. Toxicol Lett 100-101:239-246
131. Malec TS, Malec EA, Dongier M (1996) Efficacy of buspirone in alcohol dependence: a review. Alcohol Clin Exp Res 20:853-858
132. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression [see comments]. JAMA 275:761-767
133. Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56:719-724
134. Mason GA, Rezvani AH, Grady DR, Garbutt JC (1994) The sub-chronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance. Alcohol Clin Exp Res 18: 1196-1201
135. Matthews RT, German DC (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neuron by morphine. Neuroscience 11:617-625
136. McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12:339-369
137. McBride WJ, Bodart B, Lumeng L, Li TK (1995) Association between low contents of dopamine and serotonin in the nucleus accumbens and high alcohol preference. Alcohol Clin Exp Res 19:1420-1422
138. McCaul ME, Wand GE, Sullivan J, Mumford G, Ouigley J (1997) Beta-naltrexol level predicts alcohol relapse. Alcohol Clin Exp Res 21:32A
139. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, Quitkin FM (1996) Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 53:232-240
140. Meert TF (1993) Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol Alcohol 28: 157-170
141. Meert TF, Awouters F, Niemegeers CJ, Schellekens KH, Janssen PA (1991) Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats. Pharmacopsychiatry 24:159-163
142. Murphy JM, Waller MB, Gatto GJ, McBride WJ, Lumeng L, Li TK (1988) Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol 5:283-286
143. Myers RD, Lankford M (1996) Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone. Neuropsychopharmacology 14:139-149
144. 2A antagonist amperozide on alcohol-induced poikilothermia in rats. Pharmacol Biochem Behav 59:91-95
145. Myers RD, Veale WL (1968) Alcohol preference in the rat: reduction following depletion of brain serotonin. Science 160:1469-1471
146. Myers RD, Lankford M, Bjork A (1992) Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide. Pharmacol Biochem Behav 43:661-667
147. Nachman M, Lester D, LeMagnen J (1970) Alcohol aversion in the rat: Behavioral assessment of noxious drug effects. Science 168:1244-1246
148. Naranjo CA, Sellers EM (1989) Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Recent Dev Alcohol 7:255-266
149. Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984) Zimelidine-induced variations in alcohol intake by non depressed heavy drinkers. Clin Pharmacol Ther 35:374-381
150. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K (1987) Serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266-274
151. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM (1990) Fiuoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490-498
152. Naranjo CA, George SR, Bremner KE (1992a) Novel neuropharmacological treatments of alcohol dependence. Clin Neuropharmacol 15:74A-75A
153. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL (1992b) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51: 729-739
154. Naranjo CA, Bremner KE, Lanctot KL (1995) Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems. Addiction 90:87-99
155. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881-887
156. O'Malley SS, Jaffe AJ, Rode S, Rounsaville BJ (1996) Experience of a "slip" among alcoholics treated with naltrexone or placebo. Am J Psychiatry 153:281-283
157. Overstreet DH, Lee YW, Rezvani AH, Pei YH, Criswell HE, Janowsky DS (1996) Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol Clin Exp Res 20:221-227
158. 2A antagonists amperozide and FG 5974. Alcohol Clin Exp Res 21:1448-14454
159. 3 antagonists: recent advances. Prog Med Chem 29:239-270
160. Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parrot P (1995). Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 30:239-247
161. Pelc I, Verbanck P, Le Bon O, Gavrilovic M, Lion K, Lehert P (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. Br J Psychiatry 171:73-77
162. Poldrugo F (1997) Acamprosate treatment in a long-term community-based alcohol rehabilitation program. Addiction 92:1537-1546
163. Powell BJ, Campbell JL, Landon JF, Liskow BI, Thomas HM, Nickel EJ, Dale TM, Penick EC, Samuelson SD, Lacoursiere RB (1995) A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcohol Clin Exp Res 19: 462-468
164. Privette TH, Hornsby RL, Myers RD (1988) Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 5:147-152
165. Project MATCH Research Group (1993) Project MATCH: Rationale and methods for multi-site clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res 17:1130-1145
166. Putzke J, Spangler R, Tolle TR, Zieglgansberger W (1996) The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. J Pharmacol 317:39-48
167. Rezvani AH, Overstreet DH, Janowsky DS (1990) Genetic serotonin deficiency and alcohol preference in the fawn hooded rats. Alcohol Alcohol 25:573-557
168. 3 receptors. In: NIAAA (ed) Scientific meeting of the Research Society on Alcoholism. Alcohol Clin Exp Res, Santa Barbara, California, p 49A
169. Rosetti ZL, Carboni S (1995) Ethanol withdrawal is associated with increased extracellular glutamate in the rat striation. Eur J Pharmacol 283:177-183
170. Ross D, Hartmann RJ, Geller I (1976) Ethanol preference in the hamster: effects of morphine sulfate and naltrexone, a long-acting morphine antagonist. Proc West Pharmacol Soc 19: 326-330
171. Rowland NE, Barnett M (1992) Sham ingestion of alcohol in rats. Alcohol 9:75-77
172. Rowland NE, Morian KR (1994) Sham intake of ethanol in "P" rats. Alcohol 11:163-5
173. Rush CR, Pazzaglia PJ (1998) Pretreatment with isradipine, a calcium-channel blocker, does not attenuate the acute behavioral effects of ethanol in humans. Alcohol Clin Exp Res 22:539-547
174. Russell RN, McBride WJ, Lumeng L, Li TK, Murphy JM (1996) Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats. Alcohol 13:515-519
175. Samson HH, Doyle TF (1985) Oral ethanol self-administration in the rat: effect of naloxone. Pharmacol Biochem Behav 22:91-99
176. Sass H, Soyka M, Mann K, Zieglgansberger W (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence [published erratum appears in Arch Gen Psychiatry 1996 53(12):1097]. Arch Gen Psychiatry 53:673-680
177. 2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry 45:647-651
178. Sellers EM, Higgins GA, Tompkins DM, Romach MK (1992) Serotonin and alcohol drinking. NIDA Res Monogr 119:141-145
179. 3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 18:879-885
180. Shaw GK, Waller S, Majumdar SK, Alberts JL, Latham CJ, Dunn G (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 165:515-523
181. Shwartz-Stevens K, Files F, Samson H (1992) Effects of morphine and naloxone on ethanol-and sucrose-reinforced responding in non-deprived rats. Alcohol Clin Exp Res 16:822-832
182. Simpson RJ, Lawton DJ, Watt MH, Tiplady B (1981) Effect of zimelidine, a new antidepressant, on appetite and body weight. Br J Clin Pharmacol 11:96-98
183. Sinclair JD, Li TK (1989) Long and short alcohol deprivation: effects on AA and p alcohol-preferring rats. Alcohol 6:505-509
184. Smith GP (1982) The physiology of the meal. In: Silverstone T (ed) Drugs and appetite. Academic Press, London
185. Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54-58
186. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050
187. Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgansberger W (1996a) Acamprosate and alcohol: effects of alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:38-44
188. Spanagel R, Putzke J, Steffer A, Schobitz B, Zieglgansberger W (1996b) Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305: 45-50
189. Stellar JR, Stellar E (1985) The neurobiology of motivation and reward. Springer-Verlag, Berlin, Heidelberg, New York
190. Svensson L, Fahlke C, Hard E, Engel JA (1993) Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10:219-224
191. Swann AS, Johnson BA, Cloninger CR, Chen YR (1999) Alcoholism and serotonin: relationships of plasma tryptophan availability to course of illness and clinical features. Psychopharmacology 143:380-384
192. Swift RM, Whelihan W, Kuznetsov O, Buongioro G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467
193. Swift RM, Davidson D, Whelihan W, Kuznetsov O (1996) Ondansetron alters human alcohol intoxication. Biol Psychiatry 40: 514-521
194. Tamion F, Petit J, Massari P, Leroy J, Biga N, Oksenhendler G (1990) [Malignant neuroleptic syndrome during tiapride treatment]. J Toxicol Clin Exp 10:461-467
195. 3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure. Psychopharmacology 117:479-485
196. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98:45-50
197. Ulm RR, Volpicelli JR, Volpicelli LA (1995) Opiates and alcohol self-administration in animals. J Clin Psychiatry 56:5-14
198. van Ree JM, Kornet M, Goosen C (1994) Neuropeptides and alcohol addiction in monkeys. Exs 71:165-174
199. Vandel B, Bonin B, Vandel S, Blum D, Rey E, Volmat R (1984) [Interaction between tiapride and alcohol in man]. Sem Hop 60:175-177
200. Virkkunen M, Linnoila M (1990) Serotonin in early onset, male alcoholics with violent behaviour. Ann Med 22: 327-331
201. Virkkunen M, Linnoila M (1997) Serotonin in early-onset alcoholism. In: Galanter M (ed) Recent developments in alcoholism, alcohol and violence: epidemiology, neurobiology, psychology, family issues, pp 173-189
202. Volpicelli JR, Davis MA, Olgin JE (1986) Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci 38:841-847
203. Volpicelli JR, Alterman AI, Hayasgida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880
204. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995) Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry 152:613-615
205. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP (1997) Naltrexone and alcohol dependence. Role of subject compliance [see comments]. Arch Gen Psychiatry 54:737-742
206. Weiss F, Mitchiner M, Bloom FE, Koob GF (1990) Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology 101:178-186
207. Whittington MA, Little HJ (1991) A calcium channel antagonist stereoselectively decreases ethanol withdrawal hyperexcitability but not that due to bicuculline, in hippocampal slices. Br J Pharmacology 103:1313-1320
208. Whitworth AB, Fisher F, Lesch OM, Nimmerrichhter A, Oberbauer H, Platz T, Potgieter WH, Fleischhaker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347:1438-1442
209. Widdowson PS, Holman RB (1992) Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates. J Neurochem 59:157-163
210. Wiesbeck GA, Weijers HG, Chick J, Naranjo CA, Boening J (1999) Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group. Alcohol Clin Exp Res 23:230-235
211. Wise RA, Bozarth MA (1987) A psychostimulant theory of addiction. Psychol Rev 94:469-492
212. Wise RA, Raptis L (1985) Effects of pre-feeding on food-approach latency and food consumption speed in food deprived rats. Physiol Behav 35:961-963
213. Wolffgramm J, Heyne A (1995) From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat. Behav Brain Res 70:77-94
214. Wurtman JJ, Wurtman RJ (1977) Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 198:1178-1180
215. Wurtman JJ, Wurtman RJ (1979) Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats. Life Sci 24:895-903
216. Yoshimoto K, McBride WJ, Lumeng L, Li TK (1992) Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9:17-22
217. 3 receptor involvement in alcohol dependence: a microdialysis study of the nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. Alcohol Clin Exp Res 20:311A-319A
218. Zabik JE, Binkerd K, Roache JD (1985) Serotonin and ethanol aversion in the rat. In: Naranjo CA SE (ed) Research advances in new psychopharmacological treatment for alcoholism. Elsevier, Amsterdam
219. 3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells. J Pharmacol Exp Ther 278: 732-740
220. Zieglgansberger W et al. (1996) Acamprosate in relapse prevention of alcoholism. In: Soyka M (ed) Springer, Berlin Heidelberg New York, pp 65-70